Answer
Iressa (gefitinib) is indicated as monotherapy for adults with locally advanced or metastatic non-small cell lung cancer with activating mutations of EGFR-TK.
Sources for this answer
- Iressa 250mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 18Document updated
Sources checked